(Q42676780)

4 November 2017

title

Preparation and characterization of camptothecin solid lipid nanoparticles (English)

1 reference

4 November 2017

1 reference

Shi Cheng Yang

1

1 reference

4 November 2017

Jia Bi Zhu

series ordinal

2

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Drug Development and Industrial Pharmacy

4 November 2017

published in

1 reference

4 November 2017

volume

28

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

265-274

1 reference

Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Body distribution of camptothecin solid lipid nanoparticles after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

The structural basis of camptothecin interactions with human serum albumin: impact on drug stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

High-performance liquid chromatographic analysis of the antitumour drug camptothecin and its lactone ring-opened form in rat plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Influence of different parameters on reconstitution of lyophilized SLN

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120002842

21 January 2018

Identifiers

DOI

10.1081/DDC-120002842

1 reference

4 November 2017

1 reference